-
DPP-4 inhibitors surface
Time of Update: 2020-07-07
A new class of oral anti-sugar drugs known as DPP-4 inhibitors is quietly emerging in the fast-growing market for diabetes drugs, and several pharmaceutical giants are making it a standard treatme
-
Amino acid manufacturing industry is facing transformation, circular economy low-carbon environmental protection is the way out
Time of Update: 2020-07-02
China is a large country of amino acid production, but, while the amino acid industry in China is developing rapidly and the scale of products is expanding, the pollution of the environment and the
-
FDA approves a biosimilar drug for Roche's heavy breast cancer treatment herselstin
Time of Update: 2020-06-10
, it has been reported that the United States has The FDA (http:// has approved a biosimilar drug from Roche's heavy breast cancer treatment drug (http:// herceptin (quto-bee monoantigen) the
-
Coating knowledge: natural mineral coating should be considered to avoid home decoration pollution
Time of Update: 2020-04-03
Core tip: any kind of modern home building materials has its development history, so does the coating All kinds of common coatings are usually composed of dozens or even hundreds of chemical component
-
What is cat shit (civet) coffee
Time of Update: 2020-04-03
Civet coffee, also known as kopi luwak, is a rare coffee processed in an unusual way The coffee beans used to produce cat excrement coffee are not directly picked from the botanical garden, but select
-
Mechanical engineering experts share electrostatic spraying knowledge of powder coating
Time of Update: 2020-03-25
Since the electrostatic spraying machine of powder coating appeared in the market, it has been popularized and popularized all over the world with the potential of lightning However, it needs to pay m
-
The flow of talents is accelerating, and 45 executives of well-known transnational pharmaceutical enterprises will leave in 2019
Time of Update: 2019-12-27
[pharmaceutical network industry trends] at present, the global pharmaceutical market has undergone tremendous changes Innovative drugs are mainly focused on tumor, rare diseases, children's medicine
-
What new drugs will be approved for marketing in China in 2020
Time of Update: 2019-12-24
Original: sound sir The insight database screened 15 new drug varieties that are expected to be approved in 2020, which are respectively lanalurenmab injection of Takeda pharmaceutical, enmetrastuzuma
-
2019 policy bargaining drugs ranking
Time of Update: 2019-12-11
At the end of the year, the major media in various industries started a new round of inventory Throughout the pharmaceutical industry, this year's inventory of "bottom materials" is excessive From pol
-
The anti-tumor drug market is promising, with 120 million pharmaceutical companies taking the heavy weight of generic drugs
Time of Update: 2019-11-12
[trends of pharmaceutical network industry] since the 1970s, the number of cancer deaths in China has increased significantly By 2018, the incidence rate of malignant tumor has reached more than 4 mil
-
today we are no longer as we have been! Three pictures take you back to 70 years of health care in New China
Time of Update: 2019-09-28
From the establishment of the Ministry of health of the Central People's Government in 1949 to the establishment of the national health and Health Commission in 2018; from the lack of medicine in the
-
Tongrentang subsidiary's illegal production of honey, license was revoked, many people were removed from their posts, and the profit directly dropped more than 100 million yuan
Time of Update: 2019-02-12
On December 15, 2018, relevant media reported that Yancheng golden bee, the entrusted processor of honey bottled by Tongrentang bee industry, a subsidiary of Tongrentang, had "recovered expired honey
-
Anti monopoly law enforcement will strengthen the maintenance of fair competition in medicine and other markets
Time of Update: 2019-01-04
[market analysis of chinapharma.com] on January 3, the General Administration of Market Supervision issued a notice on the authorization of anti-monopoly law enforcement, aiming to strengthen and opti
-
Opportunities and challenges coexist in the development of bio innovative drugs in China
Time of Update: 2018-11-05
1 According to the official CFDA and drug delivery database, CFDA has approved a total of 32 Chinese class 1 biological drugs since 2001 and up to August 2018 (see Table 1: approval of Chinese class 1
-
The development potential of China's biomedical industry is huge, with an annual compound growth rate of 16
Time of Update: 2018-08-21
[market analysis of chinapharma.com] according to the 2017 pharmaceutical market report of the industry, the global prescription drug market will grow steadily at a compound growth rate of 6.5% in the
